...
首页> 外文期刊>Biotechnology and Health Sciences >The Effect of Myricetin Flavonoid on the Expression of Fyn Gene in Melanoma Cells (A375)
【24h】

The Effect of Myricetin Flavonoid on the Expression of Fyn Gene in Melanoma Cells (A375)

机译:杨梅素类黄酮对黑色素瘤细胞Fyn基因表达的影响(A375)

获取原文

摘要

Background: Malignant melanoma as one of the most common cancers is currently spreading worldwide. Regarding after-effectof advanced treatments, using natural products has attracted much attention. Flavonoids, polyphenol compounds rich in diet, arebeing considered for their therapeutic preventive features. Fyn gene, a member of the protein tyrosine kinase oncogene family, hasbecome an important target for therapy goals.Objectives: The aim of this study was to assess Fyn gene expression after treatment of melanoma cells with myricetin.Methods: In this study, the melanoma cells were treated with different concentrations of myricetin (0 to 100 M) and their viabilitywas determined by the methylthiazolyl diphenyl-tetrazolium bromide (MTT) assay, also the expression of Fyn gene in treatedcells with selected concentrations of myricetin (0, 20, 40, 50, and 60 M) was detected by real time quantitative polymerase chainreaction (qPCR).Results: The current investigation showed that treatment of A375 melanoma cells with the dietary flavonoid myricetin (3, 5, 7-trihydroxy-2-(3, 4, 5,-trihydroxy phenyl)-4- chromenone), resulted in decreased cell viability and increased expression of Fyn gene.The MTT assay analysis of exposed cells with different concentrations of myricetin showed that up to 25 Mof myricetin had nocytotoxicity effect on A375 cells, also with increasing of myricetin concentration, the repression of cell proliferation developed aswell.Conclusions: Real time qPCR analysis of Fyn expression in exposed cells with various concentration of myricetin leads to overexpressionof this gene, dose dependently. Through this research, it was determined that myricetin with its anti-proliferative potentialcould suppress the development of cancer cells. On the other hand, since Fyn kinase could be involved in tumorigenesis of somecancer cells, it could be concluded that myricetin could effect the carcinogenicity of Fyn function in melanoma cells.
机译:背景:恶性黑色素瘤是最常见的癌症之一,目前正在全球范围内扩散。关于高级治疗的后效应,使用天然产物引起了很多关注。类黄酮,富含饮食的多酚类化合物,因其治疗性预防功能而被考虑。蛋白酪氨酸激酶癌基因家族成员Fyn基因已成为治疗目标的重要靶标。目的:本研究旨在评估用杨梅素治疗黑素瘤细胞后Fyn基因的表达。方法:本研究中,黑素瘤用不同浓度的杨梅素(0至100 M)处理细胞,并通过甲基噻唑基二苯基溴化四氮唑(MTT)测定法测定其生存力,并通过选择浓度的杨梅素(0、20、40,通过实时定量聚合酶链反应(qPCR)检测到50和60 M)。结果:目前的研究表明,饮食中的类黄酮杨素(3,5,7-三羟基-2-(3,4)可以治疗A375黑色素瘤细胞。 ,5,-三羟基苯基)-4-色酮)导致细胞活力降低和Fyn基因表达增加.MTT分析法分析了不同浓度杨梅素对暴露细胞的影响,结果显示多达25个Mof myri cetin对A375细胞具有杀伤作用,而且随着杨梅素浓度的增加,对细胞增殖的抑制作用也逐渐增强。结论:实时荧光定量PCR对暴露于不同浓度杨梅素的细胞中Fyn表达的定量分析导致该基因的过表达,且呈剂量依赖性。通过这项研究,确定了杨梅素具有抗增殖潜力,可以抑制癌细胞的发展。另一方面,由于Fyn激酶可能参与某些癌细胞的肿瘤发生,因此可以得出结论,杨梅素可能影响Fyn功能在黑色素瘤细胞中的致癌性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号